The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Melagatran prevents tissue factor expression in human platelet-monocyte heterotypic complexes
Corresponding Author(s) : G. Mauco
g.mauco@chu-poitiers.fr
Cellular and Molecular Biology,
Vol. 54 No. 2: General Papers
Abstract
Platelets form heterotypic complexes with circulating monocytes, inducing the expression of the procoagulant Tissue Factor (TF) that leads to thrombin generation. We investigated the potential preventive effect of melagatran, a direct anti-thrombin drug, on TF expression by platelet/monocyte heterotypic complexes (PMHC) from healthy human donors. Flow cytometry and western blot analysis were performed to characterize surface and total TF protein expression in PMHC in venous blood samples drawn in the presence of heparin or heparin and melagatran (4µM). Addition of melagatran significantly lowered the percentage of TF positive PMHC (2.6±0.3 vs. 5.9±0.7 %, p<0.01). This was not due to a melagatran-induced decrease in activation of the platelets associated with monocytes in PMHC. Indeed, melagatran effect on TF expression was accompanied by an increase in cell surface P-selectin expression in PMHC (95.6±1.9 vs. 48±18 %, p<0.001), suggesting that platelet were actually more activated in PMHC from the melagatran-treated samples. Western blot analysis of PBMC extracts suggested that melagatran specifically targeted a (54kD) form of TF in monocytes. Although further investigation is warranted, these data suggest that melagatran decreases TF expression in PMHC.
Keywords
Melagatran
Tissue factor
platelet/monocyte heterotypic complexes
peripheral blood mononuclear cells
P-selectin.
Belliard, A., Mauco, G., Bonnet, M. L., Hauet, T., & Macchi, L. (2008). Melagatran prevents tissue factor expression in human platelet-monocyte heterotypic complexes. Cellular and Molecular Biology, 54(2), 1077–82. Retrieved from http://mail.cellmolbiol.org/index.php/CMB/article/view/1030
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX